相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The variability of the serological response to SARS-corona virus-2: Potential resolution of ambiguity through determination of avidity (functional affinity)
Georg Bauer
JOURNAL OF MEDICAL VIROLOGY (2021)
Genomic evidence for reinfection with SARS-CoV-2: a case study
Richard L. Tillett et al.
LANCET INFECTIOUS DISEASES (2021)
The challenge of avidity determination in SARS-CoV-2 serology
Georg Bauer et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Antibody responses to SARS-CoV-2 in patients with COVID-19
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
Christopher O. Barnes et al.
CELL (2020)
Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses
Runhong Zhou et al.
IMMUNITY (2020)
Direct Observation of Repeated Infections With Endemic Coronaviruses
Marta Galanti et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19
Naoki Kaneko et al.
CELL (2020)
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J. Mulligan et al.
NATURE (2020)
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
Sabra Klein et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors
Sarah E. Benner et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Christopher O. Barnes et al.
NATURE (2020)
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Ugur Sahin et al.
NATURE (2020)
Understanding protection from SARS-CoV-2 by studying reinfection
Julie Overbaugh
NATURE MEDICINE (2020)
Seasonal coronavirus protective immunity is short-lasting
Arthur W. D. Edridge et al.
NATURE MEDICINE (2020)
Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
Guillaume Beaudoin-Bussieres et al.
MBIO (2020)
Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective
Indu Khatri et al.
FRONTIERS IN IMMUNOLOGY (2020)
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Jeffrey Seow et al.
NATURE MICROBIOLOGY (2020)
Kinetics of Nucleo- and Spike Protein-Specific Immunoglobulin G and of Virus-Neutralizing Antibodies after SARS-CoV-2 Infection
Annabelle Stroemer et al.
MICROORGANISMS (2020)
Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates
Tiancheng Liu et al.
NATURE BIOMEDICAL ENGINEERING (2020)
Maternal immunoglobulin G avidity as a diagnostic tool to identify pregnant women at risk of congenital cytomegalovirus infection
Masatoki Kaneko et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2017)
Affinity Enhancement of Antibodies: How Low-Affinity Antibodies Produced Early in Immune Responses Are Followed by High-Affinity Antibodies Later and in Memory B-Cell Responses
Herman N. Eisen
CANCER IMMUNOLOGY RESEARCH (2014)
Antibodies with High Avidity to the gp120 Envelope Protein in Protection from Simian Immunodeficiency Virus SIVmac251 Acquisition in an Immunization Regimen That Mimics the RV-144 Thai Trial
Poonam Pegu et al.
JOURNAL OF VIROLOGY (2013)
Correlation between Dengue-Specific Neutralizing Antibodies and Serum Avidity in Primary and Secondary Dengue Virus 3 Natural Infections in Humans
Andreas Puschnik et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Waning Antibody Levels and Avidity: Implications for MMR Vaccine-Induced Protection
Mia Kontio et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Incomplete IgG response to HIV-1 proteins and low avidity levels in recently converted HIV patients treated with early antiretroviral therapy
Maria Carla Re et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
Use of an Anti-Hepatitis C Virus (HCV) IgG Avidity Assay To Identify Recent HCV Infection
Catherine Gaudy-Graffin et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
HIV-1 Infection in Zambian Children Impairs the Development and Avidity Maturation of Measles Virus-Specific Immunoglobulin G after Vaccination and Infection
Nitya Nair et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
Maria Florencia Delgado et al.
NATURE MEDICINE (2009)
GM-CSF DNA:: An adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccine
Lilin Lai et al.
VIROLOGY (2007)
Immunoglobulin G avidity in differentiation between early and late antibody responses to West Nile virus
JL Fox et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus
PN Levett et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Antibody avidity maturation during severe acute respiratory syndrome-associated coronavirus infection
PKS Chan et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Diagnostic relevance of immunoglobulin G avidity for hepatitis A virus
AM Roque-Afonso et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus
T Lazzarotto et al.
VIRAL IMMUNOLOGY (2000)